287 related articles for article (PubMed ID: 31227287)
1. Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study.
Lingaiah S; Morin-Papunen L; Risteli J; Tapanainen JS
Fertil Steril; 2019 Aug; 112(2):362-370. PubMed ID: 31227287
[TBL] [Abstract][Full Text] [Related]
2. Reference intervals for serum concentrations of three bone turnover markers for men and women.
Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
[TBL] [Abstract][Full Text] [Related]
3. Bone markers in polycystic ovary syndrome: A multicentre study.
Lingaiah S; Morin-Papunen L; Piltonen T; Puurunen J; Sundström-Poromaa I; Stener-Victorin E; Bloigu R; Risteli J; Tapanainen JS
Clin Endocrinol (Oxf); 2017 Dec; 87(6):673-679. PubMed ID: 28845895
[TBL] [Abstract][Full Text] [Related]
4. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
[TBL] [Abstract][Full Text] [Related]
5. Metformin decreases serum 8-hydroxy-2'-deoxyguanosine levels in polycystic ovary syndrome.
Sova H; Puistola U; Morin-Papunen L; Karihtala P
Fertil Steril; 2013 Feb; 99(2):593-8. PubMed ID: 23122829
[TBL] [Abstract][Full Text] [Related]
6. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
[TBL] [Abstract][Full Text] [Related]
7. Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative.
Crandall CJ; Vasan S; LaCroix A; LeBoff MS; Cauley JA; Robbins JA; Jackson RD; Bauer DC
J Bone Miner Res; 2018 Jul; 33(7):1199-1208. PubMed ID: 29923225
[TBL] [Abstract][Full Text] [Related]
8. Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.
Li M; Li Y; Deng W; Zhang Z; Deng Z; Hu Y; Xia W; Xu L
PLoS One; 2014; 9(8):e103841. PubMed ID: 25117452
[TBL] [Abstract][Full Text] [Related]
9. Trunk and Lower Extremity Movement Patterns, Stress Fracture Risk Factors, and Biomarkers of Bone Turnover in Military Trainees.
Mauntel TC; Marshall SW; Hackney AC; Pietrosimone BG; Cameron KL; Peck KY; Trump JR; Padua DA
J Athl Train; 2020 Jul; 55(7):724-732. PubMed ID: 32702112
[TBL] [Abstract][Full Text] [Related]
10. Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes Mellitus.
Nordklint AK; Almdal TP; Vestergaard P; Lundby-Christensen L; Jørgensen NR; Boesgaard TW; Breum L; Gade-Rasmussen B; Sneppen SB; Gluud C; Hemmingsen B; Krarup T; Madsbad S; Mathiesen ER; Perrild H; Tarnow L; Thorsteinsson B; Vestergaard H; Lund SS; Eiken P
Calcif Tissue Int; 2020 Aug; 107(2):160-169. PubMed ID: 32468187
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes.
Stage TB; Christensen MH; Jørgensen NR; Beck-Nielsen H; Brøsen K; Gram J; Frost M
Bone; 2018 Jul; 112():35-41. PubMed ID: 29654849
[TBL] [Abstract][Full Text] [Related]
12. Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected].
Ma L; Song Y; Li C; Wang E; Zheng D; Qu F; Zhou J
Climacteric; 2016 Aug; 19(4):400-5. PubMed ID: 27147201
[TBL] [Abstract][Full Text] [Related]
13. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.
Szulc P; Naylor K; Hoyle NR; Eastell R; Leary ET;
Osteoporos Int; 2017 Sep; 28(9):2541-2556. PubMed ID: 28631236
[TBL] [Abstract][Full Text] [Related]
14. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.
Wisłowska M; Jakubicz D; Stepień K; Cicha M
Rheumatol Int; 2009 Oct; 29(12):1403-9. PubMed ID: 19219607
[TBL] [Abstract][Full Text] [Related]
16. Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
Bønløkke SE; Rand MS; Haddock B; Arup S; Smith CD; Jensen JEB; Schwarz P; Hovind P; Oturai PS; Jensen LT; Møller S; Eiken P; Rubin KH; Hitz MF; Abrahamsen B; Jørgensen NR
Osteoporos Int; 2022 Oct; 33(10):2155-2164. PubMed ID: 35729342
[TBL] [Abstract][Full Text] [Related]
17. Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in Men.
Williams LJ; Berk M; Hodge JM; Kotowicz MA; Stuart AL; Chandrasekaran V; Cleminson J; Pasco JA
Calcif Tissue Int; 2018 Aug; 103(2):125-130. PubMed ID: 29441424
[TBL] [Abstract][Full Text] [Related]
18. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
[TBL] [Abstract][Full Text] [Related]
19. Reference intervals for bone turnover markers in Spanish premenopausal women.
Guañabens N; Filella X; Monegal A; Gómez-Vaquero C; Bonet M; Buquet D; Casado E; Cerdá D; Erra A; Martinez S; Montalá N; Pitarch C; Kanterewicz E; Sala M; Surís X; Torres F;
Clin Chem Lab Med; 2016 Feb; 54(2):293-303. PubMed ID: 26088062
[TBL] [Abstract][Full Text] [Related]
20. Effect of age-related chronic immobility on markers of bone turnover.
Chen JS; Cameron ID; Cumming RG; Lord SR; March LM; Sambrook PN; Simpson JM; Seibel MJ
J Bone Miner Res; 2006 Feb; 21(2):324-31. PubMed ID: 16418789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
